Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net Sales	$ 3,956	$ 3,396
Cost of Goods Sold	2,269	2,211
Research and Development Expense	280	299
Selling, General and Administrative Expenses	757	735
Amortization of Intangible Assets	163	101
Restructuring and Asset Related Charges - Net	70	61
Integration and Separation Costs	0	212
Other income - net	1	31
Interest Expense	10	59	[1]
Income (loss) from continuing operations before income taxes	408	(251)	[1]
Provision for (benefit from) income taxes on continuing operations	127	(67)	[1]
Income (loss) from continuing operations after income taxes	281	(184)	[1]
Income from discontinued operations after income taxes	1	360
Net income	282	176
Net income attributable to noncontrolling interests	10	12
Net income attributable to company	$ 272	$ 164
Basic earnings (loss) per share of common stock from continuing operations	$ 0.36	$ (0.26)
Basic earnings per share of common stock from discontinued operations	0	0.48
Basic earnings per share of common stock	0.36	0.22
Diluted earnings (loss) per share of common stock from continuing operations	0.36	(0.26)
Diluted earnings per share of common stock from discontinued operations	0	0.48
Diluted earnings per share of common stock	$ 0.36	$ 0.22
EID [Member]
Net Sales	$ 3,956	$ 3,396
Cost of Goods Sold	2,269	2,211
Research and Development Expense	280	299
Selling, General and Administrative Expenses	757	735
Amortization of Intangible Assets	163	101
Restructuring and Asset Related Charges - Net	70	61
Integration and Separation Costs	0	212
Other income - net	1	31
Interest Expense	42	59
Income (loss) from continuing operations before income taxes	376	(251)
Provision for (benefit from) income taxes on continuing operations	119	(67)
Income (loss) from continuing operations after income taxes	257	(184)
Income from discontinued operations after income taxes	1	360
Net income	258	176
Net income attributable to noncontrolling interests	8	10
Net income attributable to company	$ 250	$ 166

[1] Period is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X.